Nonpeptide αvβ3 antagonists: Identification of potent, chain-shortened 7-oxo RGD mimetics

Bioorganic and Medicinal Chemistry Letters

Volumn 15, Issue 6, 2005, Pages 1647-1650

  Zartman, Amy E ^a   Duong, Le T ^a   Fernandez Metzler, Carmen ^a   Hartman, George D ^a   Leu, Chih Tai ^a   Prueksaritanont, Thomayant ^a   Rodan, Gideon A ^a   Rodan, Sevgi B ^a   Duggan, Mark E ^a   Meissner, Robert S ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINYLGLYCYLASPARTYLSERINE; RECEPTOR BLOCKING AGENT; VITRONECTIN RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; DOG; DRUG IDENTIFICATION; DRUG POTENCY; NONHUMAN; PLASMA PROTEIN BINDING; RECEPTOR AFFINITY; RECEPTOR BINDING;

EID: 20044370258     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2005.01.051     Document Type: Article

References (30)

1. S.B. Rodan, and G.A. Rodan J. Endocrinol. 154 1997 47
2. J. Clover, R.A. Dodds, and M. Gowen J. Cell Sci. 103 1992 267
3. A.M. Parfitt J. Cell Biol. 55 1994 273
4. J.E. Fisher, M.P. Caulfield, M. Sato, H.A. Quartuccio, R.J. Gould, V.M. Garsky, G.A. Rodan, and M. Rosenblatt Endocrinology 132 1993 1411
5. M. Yamamoto, J.E. Fisher, M. Gentile, J.G. Seedor, C.-T. Leu, S.B. Rodan, and G.A. Rodan Endocrinology 139 1998 1411
6. T.J. Chambers, K. Fuller, J.A. Darby, J.A. Pringle, and M.A. Horton In Vitro Bone Miner. 1 1986 127
7. B.A. Crippes, V.W. Engleman, S.L. Settle, J. Delarco, R.L. Ornberg, M.H. Helfrich, M.A. Horton, and G.A. Nickols Endocrinology 137 1996 918
8. V.W. Engleman, G.A. Nickols, F.P. Ross, M.A. Horton, D.W. Griggs, S.L. Settle, P.G. Ruminski, and S.L. Teitelbaum J. Clin. Invest. 99 1997 2284
9. M.W. Lark, G.B. Stroup, R.D. Cousins, I.E. James, S.M. Hwang, J. Bradbeer, S. Hoffman, B. Lechowska, J. Vasko-Moser, D. Zembryki, B. Votta, L. Lee-Rykaczewski, D. Perng, K. Salyers, B. Smith, X. Liang, R. Dodds, K.A. Newlander, S.T. Ross, K. Erhard, W.F. Huffman, F.H. Drake, W.H. Miller, and M. Gowen Bone 22 1998 28S
10. M.W. Lark, G.B. Stroup, S.M. Hwang, I.E. James, D.J. Rieman, F.H. Drake, J.N. Bradbeer, A. Mathur, K.F. Erhard, K.A. Newlander, S.T. Ross, K.L. Salyers, B.R. Smith, W.H. Miller, W.F. Huffman, and M. Gowen J. Pharm. Exp. 91 1999 612
11. M.W. Lark, G.B. Stroup, S.M. Hwang, I.E. James, D.J. Rieman, F.H. Drake, J.N. Bradbeer, A. Mathur, K.F. Erhard, K.A. Newlander, S.T. Ross, K.L. Salyers, B.R. Smith, W.H. Miller, W.F. Huffman, and M. Gowen J. Pharm. Exp. Ther. 91 1999 612
12. W.H. Miller, D.P. Alberts, P.K. Bhatnagar, W.E. Bondinell, J.F. Callahan, R.R. Calvo, R.D. Cousins, K.F. Erhart, D.A. Heerding, R.M. Keenan, C. Kwon, P.J. Manley, K.A. Newlander, S.T. Ross, J.M. Samanem, I.N. Uzinskas, J.W. Venslavsky, C.C.-T. Yuan, R.C. Haltiwanger, M. Gowan, S.-M. Hwang, I.E. James, M.W. Lark, D.J. Rieman, G.B. Stroup, L.M. Azzarano, K.L. Salyers, B.R. Smith, K.W. Ward, K.O. Johanson, and W.F. Huffman J. Med. Chem. 43 2000 22
13. M.W. Lark, G.B. Stroup, R.A. Dodds, R.J. Kapadia, S. Hoffman, S.M. Hwang, I.E. James, B. Lechowska, X. Liang, D.J. Rieman, K.L. Salyers, K. Ward, B.R. Smith, W.H. Miller, W.F. Huffman, and M. Gowen J. Bone Miner. Res. 16 2001 319
14. G.D. Hartman, and M.E. Duggan Exp. Opin. Invest. Drugs 9 2000 1281
15. M.E. Duggan, and J.H. Hutchinson Exp. Opin. Ther. Patents 10 2000 1367
16. P.J. Coleman, B.C. Askew, J.H. Hutchinson, D.B. Whitman, J.J. Perkins, G.D. Hartman, G.A. Rodan, C.-T. Leu, T. Prueksaritanont, C. Fernandez-Metzler, K.M. Merkle, R. Lynch, J.J. Lynch, S.B. Rodan, and M.E. Duggan Bioorg. Med. Chem. Lett. 12 2002 2463
17. K.M. Brashear, C.A. Hunt, B.T. Kucer, M.E. Duggan, G.D. Hartman, G.A. Rodan, S.B. Rodan, C.-T. Leu, T. Prueksaritanont, C. Fernandez-Metzler, A. Barrish, C.F. Homnick, J.H. Hutchinson, and P.J. Coleman Bioorg. Med. Chem. Lett. 12 2002 3483
18. P.J. Coleman, K.M. Brashear, B.C. Askew, J.H. Hutchinson, C.A. McVean, L.T. Duong, B.P. Feuston, C. Fernandez-Metzler, M.A. Gentile, G.D. Hartman, D.B. Kimmel, C. Leu, L. Lipfert, K. Merkle, B. Pennypacker, T. Prueksaritanont, G.A. Rodan, G.A. Wesolowski, S.B. Rodan, and M.E. Duggan J. Med. Chem. 47 2004 4829
19. W.O. Foye Principles of Medicinal Chemistry 3rd ed. 1988 Lea and Febinger Philadelphia p 33
20. J. Wang, M.J. Breslin, P.J. Coleman, M.E. Duggan, C.A. Hunt, J.H. Hutchinson, C. Leu, S.B. Rodan, G.A. Rodan, L.T. Duong, and G.D. Hartman Bioorg. Med. Chem. Lett. 14 2004 1049
21. Merck & Co. US Patent 5 981 546, 1999
22. D.J. Mathre, T.K. Jones, L.C. Xavier, T.J. Blacklock, R.A. Reamer, J.J. Mohan, E.T.T. Jones, K. Hoogsteen, M.W. Baum, and E.J.J. Grabowski J. Org. Chem. 56 1991 751
23. E.J. Corey, R.K. Bakshi, and S. Shibata J. Am. Chem. Soc. 109 1987 5551
24. 3 receptor. For a detailed assay protocol, see M.E. Duggan, L.T. Duong, J.E. Fisher, T.G. Hamill, W.F. Hoffman, J.R. Huff, N.C. Ihle, C.-T. Leu, R.M. Nagy, J.J. Perkins, S.B. Rodan, G. Wesolowski, D.B. Whitman, A.E. Zartman, G.R. Rodan, and G.D. Hartman J. Med. Chem. 43 2000 3736
25. The OCFORM assay measures the ability of compounds to inhibit the transformation of osteoblast-like cells (1.8 cells), originally derived from mouse calvaria, into osteoclasts. For a detailed assay protocol, see Duggan, M. E. U.S. Patent 5,981,546, 1999
26. For the assay development, see G. Wesolowski, L.T. Duong, P.T. Lakkakorpi, R.M. Nagy, K. Tezuka, H. Tanaka, R.A. Rodan, and S.B. Rodan Exp. Cell Res. 219 1995 679
27. I. Nakamura, H. Tanaka, G.A. Rodan, and L.T. Duong Endocrinology 139 1998 5182
28. G.A. Marguerie, E.F. Plow, and T.S. Edgington J. Biol. Chem. 254 1979 5357
29. Log P. Measured from octanol, pH 7.4 buffer
30. B.P. Feuston, J.C. Culberson, M.E. Duggan, G.D. Hartman, C. Leu, and S.B. Rodan J. Med. Chem. 45 2002 5640